Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
NCT00600314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-01-28
Summary
This study aims to show that the MedGem indirect calorimetry measurement device will be feasible to use in children with GVHD. Also, it aims to show that children with chronic GVHD will have elevated REE that is not adequately predicted by standard equations.
Conditions
- Graft-Versus-Host Disease
Sponsors & Collaborators
-
Ann & Robert H Lurie Children's Hospital of Chicago
lead OTHER
Principal Investigators
-
Morris Kletzel, MD · Ann & Robert H Lurie Children's Hospital of Chicago
Eligibility
- Min Age
- 7 Years
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2010-09-30
- Completion
- 2010-09-30
Countries
- United States
Study Locations
More Related Trials
-
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
NCT02194439 ·Status: COMPLETED
-
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
NCT01521039 ·Status: COMPLETED
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
NCT06649201 ·Status: RECRUITING
-
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
NCT06279585 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells
NCT00731705 ·Status: WITHDRAWN
-
Chronic GVHD Response Measures Validation
NCT01902576 ·Status: ACTIVE_NOT_RECRUITING
-
Experience of Having Chronic Graft-Versus-Host Disease
NCT00353106 ·Status: COMPLETED
-
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
NCT00651716 ·Status: TERMINATED
-
Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant
NCT02526329 ·Status: WITHDRAWN ·Phase: PHASE1
-
Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT
NCT07140445 ·Status: NOT_YET_RECRUITING
-
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
NCT00361049 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
NCT05236062 ·Status: RECRUITING ·Phase: NA
-
Improving Outcomes Assessment in Chronic GVHD
NCT00637689 ·Status: ACTIVE_NOT_RECRUITING
-
Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD
NCT02511782 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease
NCT00092235 ·Status: RECRUITING
-
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric Patients
NCT03880214 ·Status: UNKNOWN
-
Toward Immune Biomarkers for Tolerance and GvHD in Humans
NCT02319226 ·Status: UNKNOWN
-
Graft-versus-host Disease Associated Myelosuppression
NCT02829216 ·Status: UNKNOWN
-
Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
NCT02067832 ·Status: ACTIVE_NOT_RECRUITING
-
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 ·Status: NOT_YET_RECRUITING
-
Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD
NCT05333029 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
NCT01911039 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
NCT07047456 ·Status: RECRUITING ·Phase: PHASE3
-
Virtual Rehabilitation in HCT
NCT05943964 ·Status: RECRUITING ·Phase: NA